Advances in chemotherapy for patients with extremity soft tissue sarcoma

Orthopedic Clinics of North America

Volumn 37, Issue 1, 2006, Pages 15-22

  Eilber, Fritz C ^a   Tap, William D ^a   Nelson, Scott D ^a   Eckardt, Jeffery J ^a   Eilber, Frederick R ^a  

^a UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DACARBAZINE; DOXORUBICIN; IFOSFAMIDE; MESNA;

ADJUVANT CHEMOTHERAPY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; HIGH RISK POPULATION; HUMAN; LIPOSARCOMA; POSTOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; SOFT TISSUE SARCOMA; SYNOVIAL SARCOMA; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; EXTREMITIES; FEMALE; HUMANS; IFOSFAMIDE; MALE; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SARCOMA; SURVIVAL ANALYSIS;

EID: 28344447733     PISSN: 00305898     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ocl.2005.07.001     Document Type: Review

References (38)

1. M. Brennan, K.M. Alektiar, and R.G. Maki Soft tissue sarcoma V.T. DeVita S. Hellmann S.A. Rosenberg Cancer. Principles and practice of oncology 2001 Lippincott Williams & Wilkins Philadelphia 1841 1891
2. F.C. Eilber, and F.R. Eilber Soft tissue sarcoma J.L. Cameron Current surgical therapy 7th edition 2001 Mosby St. Louis (MO) 1213 1218
3. American Joint Committee on Cancer Cancer staging manual 6th edition 2002 Springer New York
4. S. Singer, J.M. Corson, and R. Gonin Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma Ann Surg 219 1994 165 173
5. P.W. Pisters, D.H. Leung, and J. Woodruff Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities J Clin Oncol 14 1996 1679 1689
6. J.M. Coindre, P. Terrier, and N.B. Bui Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study on 546 patients from the French Federation of Cancer Centers Sarcoma Group J Clin Oncol 4 1996 869 877
7. J.J. Lewis, D. Leung, and E.S. Casper Multifactorial analysis of long-term follow-up (more than 5 years) of primary extremity sarcoma Arch Surg 134 1999 190 194
8. F.C. Eilber, G. Rosen, and S. Nelson High grade extremity soft tissue sarcomas: Factors predictive of local recurrence and its effect on morbidity and mortality Ann Surg 237 2 2003 218 226
9. F.C. Eilber, M.F. Brennan, and E. Riedel Prognostic factors for survival in patients with locally recurrent extremity soft tissue sarcomas Ann Surg Oncol 12 3 2005 228 236
10. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration Lancet 350 1997 1647 1654
11. J. Verweij, and C. Seynaeve The reason for confining the use of adjuvant chemotherapy in soft tissue sarcoma to the investigational setting Semin Radiat Oncol 9 4 1999 352 359
12. J.N. Cormier, X. Huang, and Y. Xing Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes J Clin Oncol 22 22 2004 4567 4574
13. K.H. Antman, L. Ryan, and A. Elias Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma J Clin Oncol 7 1 1989 126 131
14. K.H. Antman Chemotherapy of advanced sarcomas of bone and soft tissue Semin Oncol 19 1992 13 20
15. K. Antman, J. Crowley, and S.P. Balcerzak An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas J Clin Oncol 11 7 1993 1276 1285
16. T. Brodowicz, E. Schwameis, and J. Widder Intensified adjuvant IFADIC chemotherapy for adult soft tissue sarcoma: a prospective randomized feasibility trial Sarcoma 4 2000 151 160
17. E. Gortzak, A. Azzarelli, and J. Buesa A randomized phase II study on neo-adjuvant chemotherapy for "high-risk" adult soft-tissue sarcoma Eur J Cancer 37 2001 1096 1103
18. S. Frustaci, F. Gherlinzoni, and A. DePaoli Adjuvant chemotherapy for adult soft tissue sarcoma of the extremity and girdles: results of the Italian randomized cooperative trial J Clin Oncol 19 2001 1238 1247
19. S. Frustaci, A. De Paoli, and E. Bidoli Ifosfamide in the adjuvant therapy of soft tissue sarcomas Oncology 65 2 2003 80 84
20. F.C. Eilber, G. Rosen, and J. Eckardt Treatment induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high grade extremity soft tissue sarcomas J Clin Oncol 19 2001 3203 3209
21. T.F. DeLaney, I.J. Spiro, and H.D. Suit Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas Int J Radiat Oncol Biol Phys 56 4 2003 1117 1127
22. S.R. Grobmyer, R.G. Maki, and G.D. Demetri Neo-adjuvant chemotherapy for primary high grade extremity soft tissue sarcoma Ann Oncol 15 11 2004 1667 1672
23. C.D. Fletcher, K.K. Unni, F. Mertens World Health Organization Classification of Tumors Pathology and genetics of tumours of soft tissue and bone 2002 IARC Press Lyon (France) 120 123
24. C.D. Fletcher Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma Am J Surg Pathol 16 1992 213 228
25. E.C. Borden, L.H. Baker, and R.S. Bell Soft tissue sarcomas of adults: state of the translational science Clin Cancer Res 9 6 2003 1941 1956
26. F.C. Eilber, F.R. Eilber, and J. Eckardt Impact of ifosfamide-based chemotherapy on survival in patients with primary extremity synovial sarcoma [abstract 9017] Proc Am Soc Clin Oncol 23 2004 818
27. F.C. Eilber, F.R. Eilber, and J. Eckardt The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma Ann Surg 240 4 2004 686 695
28. A. Ferrari, A. Gronchi, and M. Casanova Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution Cancer 101 2004 627 634
29. S.I. Hajdu, M.H. Shiu, and J.G. Fortner Tendosynovial sarcoma: a clinicopathological study of 136 cases Cancer 39 1977 1201 1217
30. S. Singer, E.H. Baldini, and G.D. Demetri Synovial sarcoma: prognostic significance of tumor size, margin of resection and mitotic activity for survival J Clin Oncol 14 1996 1201 1208
31. J.J. Lewis, C.R. Antonescu, and D.H. Leung Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity J Clin Oncol 18 2000 2087 2094
32. A.J. Spillane, R. A'Hern, and I.R. Judson Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment J Clin Oncol 18 2000 3794 3803
33. M. Trassard, V. Le Doussal, and K. Hacene Prognostic factors in localized primary synovial sarcoma: a multicenter study of 128 adult patients J Clin Oncol 19 2001 525 534
34. G. Rosen, C. Forscher, and S. Lowenbraun Synovial sarcoma: Uniform response of metastases to high dose ifosfamide Cancer 73 1994 2506 2511
35. C.E. Kampe, G. Rosen, and F. Eilber Synovial sarcoma: A study of intensive chemotherapy in 14 patients with localized disease Cancer 72 1993 2161 2169
36. R. Landenstein, J. Treuner, and E. Koscielniak Synovial sarcoma of childhood and adolescence: report of the German CWS-81 study Cancer 71 1993 3647 3655
37. M.F. Okcu, M. Munsell, and J. Treuner Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome J Clin Oncol 21 2003 1602 1611
38. A.P. Dei Tos Liposarcoma: new entities and evolving concepts Ann Diagn Pathol 4 4 2000 252 266